↓ Skip to main content

Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.

Overview of attention for article published in Trials, May 2012
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
61 Dimensions

Readers on

mendeley
158 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Thermotherapy. An alternative for the treatment of American cutaneous leishmaniasis.
Published in
Trials, May 2012
DOI 10.1186/1745-6215-13-58
Pubmed ID
Authors

Liliana López, Martha Robayo, Margarita Vargas, Iván D Vélez

Abstract

Pentavalent antimonials (Sb5) and miltefosine are the first-line drugs for treating cutaneous leishmaniasis in Colombia; however, toxicity and treatment duration negatively impact compliance and cost, justifying an active search for better therapeutic options. We compared the efficacy and safety of thermotherapy and meglumine antimoniate for the treatment of cutaneous leishmaniasis in Colombia.

X Demographics

X Demographics

The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 158 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Spain 1 <1%
Morocco 1 <1%
Switzerland 1 <1%
Unknown 155 98%

Demographic breakdown

Readers by professional status Count As %
Student > Bachelor 23 15%
Researcher 20 13%
Student > Master 20 13%
Student > Doctoral Student 16 10%
Student > Ph. D. Student 14 9%
Other 26 16%
Unknown 39 25%
Readers by discipline Count As %
Medicine and Dentistry 38 24%
Agricultural and Biological Sciences 19 12%
Biochemistry, Genetics and Molecular Biology 13 8%
Nursing and Health Professions 9 6%
Immunology and Microbiology 8 5%
Other 20 13%
Unknown 51 32%